← Back to Clinical Trials
Recruiting NCT07123298

NCT07123298 CAPABLE Care + Connect

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07123298
Status Recruiting
Phase
Sponsor Johns Hopkins University
Condition Social Isolation in Older Adults
Study Type INTERVENTIONAL
Enrollment 450 participants
Start Date 2025-08-14
Primary Completion 2027-05

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
CAPABLE Care + Connect - Open Label PilotCAPABLE Care + Connect - Pilot

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 450 participants in total. It began in 2025-08-14 with a primary completion date of 2027-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In this evaluation scale-up research project, the investigators seek to test an implementation of CAPABLE on the infrastructure of home-based primary care for individuals who may experience social isolation and/or loneliness. These two home-based care programs may improve each other and provide opportunity to further improve quality of life for people living with disabilities and the caregivers. The purpose of this mixed methods study is to adapt and test CAPABLE, an existing evidence-based program, to a new target population with the scalable infrastructure of home-based primary care.

Eligibility Criteria

Inclusion Criteria: * Any patient currently in JHOME * At risk for or experiencing social isolation as defined by the Lubben Social Network Scale 6 item score less than or equal 12 points or loneliness as defined by the UCLA Loneliness Scale 3 item score of 6 to 9 points * Cognitive inclusion criteria Montreal Cognitive Assessment (MOCA) \>23 as determined by referring JHOME study team member provider * English speaking (measures are standardized in English) * Ability to participate in an approximately 45-60 min virtual or in person meeting * Eligible for CAPABLE * 50 years or older * Not hospitalized over night more than 4 times in the last 12 months * Have some difficulty with any ADL * Cognitively intact * Live in Baltimore County or Baltimore City * Not receiving active cancer treatment * Interested in participating in CAPABLE Care partners will be included if the care partners provide \> 10 hours of care/week Exclusion Criteria: * Terminally ill * live in long term care setting * receiving active cancer treatment Standard of Care/Comparison group Inclusion Criteria: • Any patient currently in JHOME who did not receive the CAPABLE intervention

Contact & Investigator

Central Contact

Chloe Wynn, MS

✉ cwynn3@jh.edu

📞 667-208-7444

Principal Investigator

Thomas Cudjoe, MD, MPH, MA

PRINCIPAL INVESTIGATOR

Johns Hopkins University

Frequently Asked Questions

Who can join the NCT07123298 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, studying Social Isolation in Older Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07123298 currently recruiting?

Yes, NCT07123298 is actively recruiting participants. Contact the research team at cwynn3@jh.edu for enrollment information.

Where is the NCT07123298 trial being conducted?

This trial is being conducted at Baltimore, United States.

Who is sponsoring the NCT07123298 clinical trial?

NCT07123298 is sponsored by Johns Hopkins University. The principal investigator is Thomas Cudjoe, MD, MPH, MA at Johns Hopkins University. The trial plans to enroll 450 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology